Galdu-irabazien kontua
CHAMPIONS ONCOLOGY, INC.
CSBR
Errendimenduaren laburpena
Egin klik taulako edozein lerrotan grafikoan gehitzeko
milioika USDtan
| Neurria | Apr 30, 2025 2025 FY | Apr 30, 2024 2024 FY | Apr 30, 2023 2023 FY | Apr 30, 2022 2022 FY | Apr 30, 2021 2021 FY | Apr 30, 2020 2020 FY | Apr 30, 2019 2019 FY | Apr 30, 2018 2018 FY | Apr 30, 2017 2017 FY | Apr 30, 2016 2016 FY | Apr 30, 2015 2015 FY | Apr 30, 2014 2014 FY | Apr 30, 2013 2013 FY | Apr 30, 2012 2012 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Diru-sarrerak
|
56.94 | 50.16 | 53.87 | 49.11 | 41.04 | 32.12 | 27.07 | - | - | - | - | - | - | - |
|
Diru-sarreren kostua
|
28.39 | 29.40 | 29.53 | 23.63 | 21.45 | - | - | - | - | - | - | - | - | - |
|
Irabazi gordina
|
28.56 | 20.75 | 24.34 | 25.48 | 19.59 | 32.12 | 27.07 | - | - | - | - | - | - | - |
|
Ustiapen-gastuak
|
52.39 | 57.51 | 59.13 | 48.50 | 40.67 | 33.93 | 26.80 | 21.60 | 22.22 | 21.50 | 22.10 | 17.81 | 14.54 | 16.21 |
|
Ikerketa eta garapena
|
6.83 | 9.54 | 11.55 | 9.37 | 7.20 | 5.85 | 4.80 | 4.40 | 4.29 | 4.19 | 4.85 | 2.27 | 1.92 | 2.94 |
|
Salmentak, orokorrak eta administratiboak
|
9.34 | 11.07 | 10.24 | 9.12 | 6.51 | 6.61 | 4.68 | 4.07 | 4.96 | 5.17 | 5.34 | 6.13 | 4.63 | 5.45 |
|
Beste ustiapen-gastu batzuk
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Ustiapen-irabaziak
|
-23.84 | -36.76 | -34.79 | -23.03 | -21.08 | -1.80 | 0.27 | -21.60 | -22.22 | -21.50 | -22.10 | -17.81 | -14.54 | -16.21 |
|
Ez-ustiapeneko diru-sarrerak
|
-28.46 | -29.45 | -29.52 | -23.61 | -21.52 | 0.04 | -0.04 | -0.09 | -0.06 | -0.04 | 0.23 | -1.13 | -0.10 | 0.40 |
|
Interesen diru-sarrerak
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Interesen gastuak
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Beste ez-ustiapeneko diru-sarrerak/gastuak
|
0.07 | 0.05 | -0.01 | -0.02 | 0.07 | -0.04 | -0.04 | -0.09 | -0.06 | -0.04 | -0.17 | -0.16 | -0.03 | - |
|
Zerga aurreko irabazia
|
4.63 | -7.31 | -5.27 | 0.58 | 0.44 | -1.85 | 0.23 | -1.44 | -6.87 | -10.35 | -13.01 | -7.39 | -6.32 | -8.66 |
|
Zerga-gastua
|
-0.08 | -0.03 | 0.07 | 0.04 | 0.08 | 0.13 | 0.10 | 0.03 | 0.02 | 0.09 | -13.01 | -7.39 | -6.32 | -8.66 |
|
Partaidetza ez-kontrolatzailea
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Irabazi garbia
|
4.70 | -7.28 | -5.34 | 0.55 | 0.36 | -1.98 | 0.13 | -1.48 | -6.88 | -10.45 | 0.00 | 0.00 | 0.00 | 0.00 |
Informazio osagarria
Akzioko datuak, eratorritakoak eta bestelakoak — ez dira galdu-irabazien kontuaren parte
milioika USDtan, bestela adierazi ezean
| Neurria | Apr 30, 2025 2025 FY | Apr 30, 2024 2024 FY | Apr 30, 2023 2023 FY | Apr 30, 2022 2022 FY | Apr 30, 2021 2021 FY | Apr 30, 2020 2020 FY | Apr 30, 2019 2019 FY | Apr 30, 2018 2018 FY | Apr 30, 2017 2017 FY | Apr 30, 2016 2016 FY | Apr 30, 2015 2015 FY | Apr 30, 2014 2014 FY | Apr 30, 2013 2013 FY | Apr 30, 2012 2012 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Amortizazioa eta balio-galera
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
-22.20 | -34.89 | -32.54 | -21.40 | -19.90 | -0.98 | 0.88 | -21.24 | -22.05 | -21.34 | -21.89 | -17.60 | -14.54 | -16.21 |
|
Akzioko irabazia (oinarrizkoa)
|
0.34 | -0.54 | -0.39 | 0.04 | 0.03 | -0.17 | 0.01 | - | - | -1.20 | -0.18 | - | - | - |
|
EPS diluitua
|
0.33 | -0.54 | -0.39 | 0.04 | 0.02 | -0.17 | 0.01 | - | - | -1.20 | -0.18 | - | - | - |
|
Akzioen batez besteko haztatua
|
13.66 | 13.55 | 13.54 | 13.20 | 13.14 | 11.84 | 11.34 | - | - | 8.70 | 71.82 | - | - | - |
|
Akzioen batez besteko haztatu diluitua
|
14.27 | 13.55 | 13.54 | 14.16 | 14.57 | 11.84 | 14.10 | - | - | 8.70 | 77.09 | - | - | - |
|
Irabazi globala
|
- | - | - | - | - | - | - | - | - | - | -13.14 | -7.31 | -6.31 | -8.72 |